RealSeq Biosciences

RealSeq technology used to explore the fascinating world of phasiRNAs- phased, small interfering RNAs! https://lnkd.in/g5gD75vd

The Innovator Summit brings together the brightest minds and cutting-edge technologies in the MedTech and Biotech industry, and we are proud to be an Alumni! #BioToolsInnovator #RealSeq #BiotechInnovation #NextGenSequencing #InnovationSummit #BiotechCommunity

Join us on June 12 at 11:10 am EDT for the Multi-Omics & Microbiome Virtual Conference! #RealSeq #BiotechInnovation #MultiOmics #Microbiome #ConferenceAnnouncement

🌟 Research Publication Alert! 🌟 A new study published in Experimental & Molecular Medicine offers groundbreaking insights into the translation dynamics of SARS-CoV-2 in lung tissues during severe COVID-19. This pioneering research utilized advanced tissue-optimized ribosome profiling (Ribo-seq) and RealSeq ®-AC to map out the complex interactions between the virus and host cell machinery at a molecular level, providing a detailed temporal analysis of gene translation. The study, "Temporal Translation Profiles of SARS-CoV-2 and Host Genes in Infected Lung Tissue," reveals significant findings about how SARS-CoV-2 disrupts normal cellular functions, leading to severe pathogenic effects. Key observations include: ⚫ The identification of novel pseudoribosomal RNP interactions that suggest a mechanism by which the virus may impede the normal translation elongation process within the host cells. ⚫ Documentation of ribosome stalling on specific codons and compromised translation of essential genes related to immunity and metabolism, despite their increased transcription. This disruption could be a critical factor contributing to disease severity. These insights are crucial for understanding the molecular basis of SARS-CoV-2 pathogenesis and can potentially inform the development of targeted therapies to mitigate the impact of the virus. For a deeper dive into these transformative findings, read the full article in Experimental & Molecular Medicine : https://lnkd.in/gnxCyr2S #ViralPathogenesis #SARSCoV2 #NatureBiology #Genomics #COVID19Research #ScientificDiscovery #HealthcareInnovation

Congratulations to CAP Portfolio company @RealSeq who have successfully secured a patent for their innovative RNA sequencing method! This is a significant milestone and a testament to the hard work, ingenuity, and dedication of the entire team at RealSeq. Here’s to many more innovations and successes in the future! #CharlestonAngelPartners #RealSeq #CAP #AngelInvesting

Unlocking the Future of Small RNA Sequencing with RealSeq Biosciences! At RealSeq Biosciences, we are dedicated to advancing the field of RNA sequencing. Our latest innovative RealSeq®-Biofluids kit is designed to provide researchers with the tools they need to achieve accurate and reliable results for RNA analysis. Why RealSeq®-Biofluids Kit? Enhanced Read Consistency: Experience significantly less ligation bias with our novel single adapter technology, which improves the detection of a diverse pool of small RNAs including rRNA, tsRNA, and piRNA. Wider Detection Range:  Our kit reduces inter-library variability, ensuring consistent and reliable data crucial for research and diagnostics. Sensitive and Robust: Tailored to address the unique challenges of biofluid samples, our kit excels in detecting even the smallest RNA fragments, ideal for liquid biopsy applications. Our technology, based on a unique single adapter and circularization method, not only reduces incorporation bias but also amplifies the detection capabilities of our kit. This breakthrough enables researchers to explore new areas, such as sensitive identification of small RNA biomarkers crucial for early disease diagnosis and monitoring. Stay tuned for more updates as we continue to innovate and lead in RNA analysis! #RealSeq #RNAResearch #RNADetection #BiotechInnovation #HealthcareInnovation #Biotech #Genomics #LiquidBiopsy #PrecisionMedicine #MedicalResearch

🎉 Exciting News from RealSeq Biosciences!  We are thrilled to announce that RealSeq Biosciences has been awarded a patent for our innovative RNA sequencing method! 🧬 This groundbreaking technology marks a significant advancement in RNA sequencing, offering unparalleled accuracy and efficiency for transcriptomic analysis.  A huge congratulations to our incredible team for their dedication and hard work in developing this cutting-edge method. 👏 We invite you to read the full press release to learn more about our patented technology and its impact on the future of RNA research: https://lnkd.in/gEJURx7K #biotechnology #genomics #innovation #RNAsequencing #RealSeqBiosciences #patent #research#healthcare #science

Happy to share that I'll be speaking at Multi-Omics & Microbiome Virtual Conference! Make sure to attend it on June 11.

Act fast and sign up for our Small RNA sequencing pilot program before it's too late! Limited spots available. #SmallRNA #Sequencing